Frontlight ResearchEarly access
Kidney cancer trials in Russia
4 of 6 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleCombinations With Lenvatinib in Patients With Metastatic Chromophobe Renal Cell Carcinoma: a Phase 2 Study.
- Where
- Chelyabinsk, Krasnoyarsk, Orenburg, Saint Petersburg, Saratov, Ufa, Yekaterinburg
- Age
- 18 months and over
- People
- 40
- Run by
- Kidney Cancer Research Bureau
See details and how to joinNCT07937553 - Phase 1/2Taking peopleA Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1
- Where
- Kazan', Krasnoyarsk, Moscow, Saint Petersburg, Ufa
- Age
- 18 years and over
- People
- 64
- Run by
- Kidney Cancer Research Bureau
See details and how to joinNCT07292168 - Phase 2Taking peopleLenvatinib And Stereotactic radiothErapy With pembRolizumab in Metastatic Kidney Cancer Patients
- Where
- Kazan', Moscow, Orenburg, Saint Petersburg, Tyumen, Ufa, Ulyanovsk
- Age
- 18 years and over
- People
- 150
- Run by
- Kidney Cancer Research Bureau
See details and how to joinNCT07928167 - Phase 2Active, not recruitingAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Saint Petersburg
- Age
- 18 years and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00